M. Dik, C. Jonker, C. Hack, J. Smit, H. Comijs et al., Serum inflammatory proteins and cognitive decline in older persons, Neurology, vol.64, issue.8, pp.1371-1377, 2005.
DOI : 10.1212/01.WNL.0000158281.08946.68

D. Alley, E. Crimmins, A. Karlamangla, P. Hu, and T. Seeman, Inflammation and Rate of Cognitive Change in High-Functioning Older Adults, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol.63, issue.1, pp.50-55, 2008.
DOI : 10.1093/gerona/63.1.50

J. Weuve, P. Ridker, N. Cook, J. Buring, and F. Grodstein, High-Sensitivity C-Reactive Protein and Cognitive Function in Older Women, Epidemiology, vol.17, issue.2, pp.183-189, 2006.
DOI : 10.1097/01.ede.0000198183.60572.c9

K. Yaffe, K. Lindquist, and B. Penninx, Inflammatory markers and cognition in well-functioning African-American and white elders, Neurology, vol.61, issue.1, pp.76-80, 2003.
DOI : 10.1212/01.WNL.0000073620.42047.D7

C. Wilson, H. Cohen, and C. Pieper, Cross-Linked Fibrin Degradation Products (D-Dimer), Plasma Cytokines, and Cognitive Decline in Community-Dwelling Elderly Persons, Journal of the American Geriatrics Society, vol.45, issue.(8, pp.1374-1381, 2003.
DOI : 10.1046/j.1532-5415.2003.51454.x

S. Rafnsson, I. Deary, and F. Smith, Cognitive Decline and Markers of Inflammation and Hemostasis: The Edinburgh Artery Study, Journal of the American Geriatrics Society, vol.102, issue.5, pp.700-707, 2007.
DOI : 10.1111/j.1532-5415.2007.01158.x

J. Weaver, M. Huang, M. Albert, T. Harris, J. Rowe et al., Interleukin-6 and risk of cognitive decline: MacArthur Studies of Successful Aging, Neurology, vol.59, issue.3, pp.371-378, 2002.
DOI : 10.1212/WNL.59.3.371

J. Noble, J. Manly, N. Schupf, M. Tang, R. Mayeux et al., Association of C-Reactive Protein With Cognitive Impairment, Archives of Neurology, vol.67, issue.1, pp.87-92, 2010.
DOI : 10.1001/archneurol.2009.308

T. Salthouse, The processing-speed theory of adult age differences in cognition., Psychological Review, vol.103, issue.3, pp.403-428, 1996.
DOI : 10.1037/0033-295X.103.3.403

R. Schmidt, H. Schmidt, J. Curb, K. Masaki, L. White et al., Early inflammation and dementia: A 25-year follow-up of the Honolulu-Asia aging study, Annals of Neurology, vol.51, issue.2, pp.168-174, 2002.
DOI : 10.1002/ana.10265

C. Teunissen, M. Van-boxtel, and H. Bosma, Inflammation markers in relation to cognition in a healthy aging population, Journal of Neuroimmunology, vol.134, issue.1-2, pp.142-150, 2003.
DOI : 10.1016/S0165-5728(02)00398-3

A. Jefferson, J. Massaro, and P. Wolf, Inflammatory biomarkers are associated with total brain volume: The Framingham Heart Study, Neurology, vol.68, issue.13, pp.1032-1038, 2007.
DOI : 10.1212/01.wnl.0000257815.20548.df

C. Satizabal, Y. Zhu, B. Mazoyer, C. Dufouil, and C. Tzourio, Circulating IL-6 and CRP are associated with MRI findings in the elderly: The 3C-Dijon Study, Neurology, vol.78, issue.10, pp.720-727, 2012.
DOI : 10.1212/WNL.0b013e318248e50f

URL : https://hal.archives-ouvertes.fr/hal-01166212

M. Fornage, Y. Chiang, O. Meara, and E. , Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study, Stroke, vol.39, issue.7, pp.1952-1959, 2008.
DOI : 10.1161/STROKEAHA.107.508135

M. Rattazzi, M. Puato, E. Faggin, B. Bertipaglia, A. Zambon et al., C-reactive protein and interleukin-6 in vascular disease, Journal of Hypertension, vol.21, issue.10, pp.1787-1803, 2003.
DOI : 10.1097/00004872-200310000-00002

R. Schmidt, H. Schmidt, J. Curb, K. Masaki, L. White et al., Early inflammation and dementia: A 25-year follow-up of the Honolulu-Asia aging study, Annals of Neurology, vol.51, issue.2, pp.168-174, 2002.
DOI : 10.1002/ana.10265

G. Sullivan, I. Sarembock, and J. Linden, The role of inflammation in vascular diseases, J Leukoc Biol, vol.67, issue.34, pp.591-602, 2000.

R. Ross, Atherosclerosis--an inflammatory disease, N Engl J Med, vol.340, issue.35, pp.115-126, 1999.

T. Hoshi, K. Kitagawa, H. Yamagami, S. Furukado, H. Hougaku et al., Relations of Serum High-Sensitivity C-Reactive Protein and Interleukin-6 Levels With Silent Brain Infarction, Stroke, vol.36, issue.4, pp.768-772, 2005.
DOI : 10.1161/01.STR.0000158915.28329.51

V. Marchesi, Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy, The FASEB Journal, vol.25, issue.1, pp.5-13, 2011.
DOI : 10.1096/fj.11-0102ufm

B. Martin, C. Szekely, and J. Brandt, Cognitive function over time in the Alzheimer's Disease Antiinflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib, Arch Neurol, vol.65, issue.38, pp.896-905, 2008.

J. Breitner, L. Baker, and T. Montine, Extended results of the Alzheimer???s disease anti-inflammatory prevention trial, Alzheimer's & Dementia, vol.7, issue.4, pp.402-411, 2011.
DOI : 10.1016/j.jalz.2010.12.014

E. Van, P. Eikelenboom, and H. Comijs, Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease, Arch Gen Psychiatry, vol.66, issue.40, pp.1263-1270, 2009.